The groundbreaking treatment of the medication represents a major development in the handling of type 2 diabetes. Different to existing therapies, tirzepatide targets dual pathways – GLP-1 and glucose-dependent https://tirzepatidepeptide861157.post-blogs.com/62905634/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment